Name: UMIN ID:
Unique ID issued by UMIN | UMIN000034454 |
---|---|
Receipt number | R000039287 |
Scientific Title | A Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeated doses of ART-648/TAK-648 in healthy Japanese volunteers |
Date of disclosure of the study information | 2018/11/01 |
Last modified on | 2020/10/12 09:20:07 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/10/11 16:55:59 | ||
2 | Update | 2019/03/07 14:49:07 | Recruitment status |
|
3 | Update | 2019/10/17 14:11:42 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Address Address Organization Organization Address Address Tel |
|
4 | Update | 2019/10/17 14:14:24 | Date of IRB Last follow-up date |
|
5 | Update | 2020/04/14 13:33:28 | No. of arms Interventions/Control_6 Interventions/Control_6 Interventions/Control_7 Interventions/Control_7 Target sample size |
|
6 | Update | 2020/04/14 13:34:48 | Last follow-up date |
|
7 | Update | 2020/10/12 09:13:51 | Primary outcomes Key secondary outcomes |
|
8 | Update | 2020/10/12 09:19:25 | Recruitment status Last follow-up date |
|
9 | Update | 2020/10/12 09:20:07 | Number of participants that the trial has enrolled |